Company Profile - JSP PHARMACEUTICAL MANUFACTURING (THAILAND) PUBLIC COMPANY LIMITED สำนักงานคณะกรรมการกำกับหลักทรัพย์และตลาดหลักทรัพย์ Printed on 09 August 2024 20:12 Company Profile JSP
resolutions as following: (1) Approved the Balance Sheet and the Profits and Loss Statement as of 31 December 2019 (2) Approved the dividend payment from the company’s performance of the period 1 July – 31
1 No. ECF2 029/2561 28 June 2018 Subject The Entering into an Investment of the construction of the Manufacturing Plant and Distributing of the Medium Density Fiber Board or MDF Board in Narathiwat
addition, the economic impact of Covid-19 will be only fully visible in the Q2-Q4 period of the year. However, as our business is essential to many manufacturing processes, and as we are quite diversified
commercial and passenger cars. Export-related manufacturing production, especially automotive, has continued to improve. The consensus view for 4% GDP growth in 2018 maybe revised upwards given the strong end
positive the groups funding is from the shareholders equity. Major Factors which could have an Impact on the Company's Performance The company business is that of an electronics manufacturing service company
funding is from the shareholders equity. Major Factors which could have an Impact on the Company's Performance The company business is that of an electronics manufacturing service company. The company
Page 2 of 3 funding is from the shareholders equity. Major Factors which could have an Impact on the Company's Performance The company business is that of an electronics manufacturing service company
Company's Performance The company business is that of an electronics manufacturing service company. The company manufactures products on behalf of its customers for shipment to them or their customers